Sectors
The Pharmstandard-backed pharmaceutical company is seeking to raise the cash in an IPO four months after it closed part of a $45m series D round.
The Novartis-backed pharmaceutical company will use the proceeds to fund pivotal tests for its prostate cancer drug.
Healthcare management technology company TriZetto has been acquired by IT and consulting company Cognizant Technology Solutions for $2.7bn.
Kolltan, which is backed by Purdue Pharma and Gilead Sciences, will use the proceeds to advance its candidates through early-stage clinical trials.
The internet company has now made about $300m in total from share sales in publicly traded payment company Qiwi.
The medical device developers have agreed a merger, and Merck and Mayo Clinic, both of which have funded Preventice, will continue to support the new company.
The car rental company is one of several cornerstone investors that will invest $30m as the China-based company seeks $467m from a Hong Kong initial public offering.
The pharmaceutical company, which is developing treatments for disorders including neuropathic pain and Crohn's Disease, is backed by investors including AbbVie.
The offering will value the corporate-backed incubator and venture fund at approximately $6.45bn.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
